CARA
Cara Therapeutics, Inc.
Total Trades
49
Buys
0
Sells
45
Largest Trade
N/A
Insiders
9
Institutional Funds
1
Inst. Value
<$1K
Activist Filings
13
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Posner Christopher | PRESIDENT AND CEO | SELL | $1K–$15K | 4K | $0.29 | Nov 6, 2024 |
| Posner Christopher | PRESIDENT AND CEO | SELL | $1K–$15K | 4K | $0.35 | Aug 2, 2024 |
| Goncalves Joana | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 3K | $0.83 | Apr 9, 2024 |
| Terrillion Scott | SEC'Y; CHIEF COMPL… | SELL | $1K–$15K | 3K | $0.83 | Apr 9, 2024 |
| Terrillion Scott | SEC'Y; CHIEF COMPL… | SELL | $1K–$15K | 3K | $0.89 | Mar 4, 2024 |
| Posner Christopher | PRESIDENT AND CEO | SELL | $1K–$15K | 6K | $0.89 | Mar 4, 2024 |
| Goncalves Joana | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 3K | $0.89 | Mar 4, 2024 |
| Terrillion Scott | SEC'Y; CHIEF COMPL… | SELL | $1K–$15K | 8K | $0.53 | Feb 12, 2024 |
| Maynard Ryan D | CHIEF FINANCIAL OF… | SELL | $1K–$15K | 5K | $0.53 | Feb 12, 2024 |
| Goncalves Joana | CHIEF MEDICAL OFFI… | SELL | $1K–$15K | 8K | $0.53 | Feb 12, 2024 |
| Posner Christopher | PRESIDENT AND CEO | SELL | $15K–$50K | 36K | $0.53 | Feb 12, 2024 |
| Posner Christopher | PRESIDENT AND CEO | GRANT | N/A | 63K | — | Feb 5, 2024 |
| Posner Christopher | PRESIDENT AND CEO | SELL | $1K–$15K | 5K | $0.55 | Feb 5, 2024 |
| Posner Christopher | President and CEO | SELL | $1K–$15K | 4K | $1.22 | Nov 3, 2023 |
| Posner Christopher | President and CEO | SELL | $1K–$15K | 4K | $3.07 | Aug 4, 2023 |
| Terrillion Scott | Sec'y; Chief Compl… | SELL | $1K–$15K | 2K | $3.51 | Jun 27, 2023 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off | SELL | $1K–$15K | 3K | $3.51 | Jun 27, 2023 |
| Goncalves Joana | Chief Medical Offi… | SELL | $1K–$15K | 3K | $3.51 | Jun 27, 2023 |
| Posner Christopher | President and CEO | SELL | $15K–$50K | 4K | $4.40 | May 9, 2023 |
| Terrillion Scott | Sec'y; Chief Compl… | SELL | $1K–$15K | 2K | $4.91 | Apr 6, 2023 |
| Goncalves Joana | Chief Medical Offi… | SELL | $1K–$15K | 2K | $4.91 | Apr 6, 2023 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off | SELL | $1K–$15K | 3K | $4.91 | Apr 6, 2023 |
| Posner Christopher | President and CEO | SELL | $50K–$100K | 6K | $9.71 | Mar 7, 2023 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off | SELL | $50K–$100K | 7K | $9.71 | Mar 7, 2023 |
| Terrillion Scott | Sec'y; Chief Compl… | SELL | $50K–$100K | 6K | $9.71 | Mar 7, 2023 |
| Goncalves Joana | Chief Medical Offi… | SELL | $50K–$100K | 6K | $9.71 | Mar 7, 2023 |
| Goncalves Joana | Chief Medical Offi… | SELL | $15K–$50K | 2K | $10.20 | Feb 17, 2023 |
| Posner Christopher | President and CEO | SELL | $15K–$50K | 4K | $11.80 | Feb 3, 2023 |
| Goncalves Joana | Chief Medical Offi… | SELL | $15K–$50K | 2K | $10.81 | Jan 19, 2023 |
| Goncalves Joana | Chief Medical Offi… | SELL | $15K–$50K | 2K | $10.18 | Jan 3, 2023 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off | SELL | $15K–$50K | 4K | $11.27 | Dec 23, 2022 |
| Goncalves Joana | Chief Medical Offi… | SELL | $15K–$50K | 3K | $11.27 | Dec 23, 2022 |
| Terrillion Scott | Sec'y; Chief Compl… | SELL | $15K–$50K | 3K | $11.27 | Dec 23, 2022 |
| Posner Christopher | President and CEO | SELL | $100K–$500K | 14K | $11.13 | Nov 18, 2022 |
| VOGELBAUM MARTIN | Director | SELL | $100K–$500K | 11K | $10.28 | Sep 16, 2022 |
| Ives Jeffrey L. | Director | SELL | $15K–$50K | 4K | $9.05 | Jul 19, 2022 |
| BAINS HARRISON M JR | Director | SELL | $50K–$100K | 7K | $9.05 | Jul 19, 2022 |
| Terrillion Scott | Sec'y; Chief Compl… | SELL | $15K–$50K | 2K | $11.91 | Apr 5, 2022 |
| Goncalves Joana | Chief Medical Offi… | SELL | $15K–$50K | 2K | $11.91 | Apr 5, 2022 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off | SELL | $15K–$50K | 2K | $11.91 | Apr 5, 2022 |
| Posner Christopher | President and CEO | SELL | $15K–$50K | 2K | $12.67 | Apr 5, 2022 |
| Reilly Thomas Charles | CFO | SELL | $15K–$50K | 2K | $11.38 | Mar 4, 2022 |
| Terrillion Scott | Sec'y; Chief Compl… | SELL | $15K–$50K | 2K | $11.38 | Mar 4, 2022 |
| Terrillion Scott | Sec'y; Chief Compl… | GRANT | N/A | 25K | — | Mar 1, 2022 |
| Terrillion Scott | Sec'y; Chief Compl… | SELL | $15K–$50K | 2K | $10.29 | Mar 1, 2022 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off | GRANT | N/A | 20K | — | Mar 1, 2022 |
| Menzaghi Frederique Ph.D. | Chief Scientific Off | SELL | $15K–$50K | 2K | $10.29 | Mar 1, 2022 |
| Goncalves Joana | Chief Medical Offi… | SELL | $15K–$50K | 2K | $10.29 | Mar 1, 2022 |
| Goncalves Joana | Chief Medical Offi… | GRANT | N/A | 20K | — | Mar 1, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Mar 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Farther Finance Advisors, LLC | 9 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Dec 18, 2024
13.5%
7.4M shares
SC 13D · Oct 30, 2024
13.5%
739.7M shares
SC 13G/A · Jul 8, 2024
1.4%
745K shares
Bain Capital Life Sciences Opportunities III, LP 2
SC 13G/A · Feb 13, 2024
12.0%
0 shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
4.8%
2.6M shares
SC 13G/A · Jan 29, 2024
6.5%
3.6M shares
SC 13G/A · Jul 25, 2023
13.7%
7.4M shares
SC 13G/A · Jul 7, 2023
6.9%
3.7M shares
SC 13G/A · Jan 26, 2023
14.4%
7.7M shares
SC 13G/A · Jan 20, 2023
14.4%
7.7M shares
Bain Capital Life Sciences Opportunities III, LP
SC 13G · Nov 18, 2022
5.0%
2.7M shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares
SC 13G/A · Feb 14, 2022
0.0%
0 shares